Related Experiment Video

Updated: Jul 11, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy

Yoshinori Nishijima1, Arun Sridhar, Serge Viatchenko-Karpinski

  • 1Department of Veterinary Biosciences, United States.

Life Sciences
|September 22, 2007
PubMed

Insights

Cardiac resynchronization therapy (CRT) improves heart failure (HF) by enhancing left ventricular structure and myocyte function. This study reveals CRT

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Biomedical Engineering

Background:

  • Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in heart failure (HF) patients.
  • The underlying mechanisms of CRT's efficacy in HF remain poorly understood.
  • Understanding these mechanisms is crucial for advancing HF pathogenesis research and identifying recovery pathways.

Purpose of the Study:

  • To investigate the cellular mechanisms responsible for the functional improvements observed in chronic heart failure following CRT.
  • To elucidate how CRT impacts left ventricular (LV) structure, myocyte electrophysiology, and intracellular calcium regulation in a canine model of nonischemic cardiomyopathy.

Main Methods:

  • Utilized a canine model of chronic nonischemic cardiomyopathy.
  • Administered CRT for 9 months to a subset of dogs with heart failure.
  • Assessed functional responses via 6-minute walk tests, echocardiograms, and electrocardiograms.
  • Isolated LV midmyocardial myocytes to study electrophysiology and intracellular calcium handling.

Main Results:

  • CRT significantly improved cardiac structure, reducing LV volumes, diameters, and mass compared to untreated HF.
  • CRT reversed prolonged LV myocyte repolarization and normalized resting membrane potential depolarization.
  • CRT enhanced intracellular calcium regulation, improving reduced calcium levels observed in HF.
  • CRT did not affect the increase in LV interstitial fibrosis associated with HF.

Conclusions:

  • CRT offers significant benefits in chronic heart failure by improving LV structure.
  • Enhanced LV myocyte electrophysiology and calcium regulation contribute to CRT's beneficial effects.
  • Improved left ventricular myocyte function is a key factor in the therapeutic efficacy of CRT.

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation08:43

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

Published on: March 17, 2023

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...